Ozempic is a GLP-1 medication. Specifically, it belongs to a class of drugs called GLP-1 receptor agonists, which mimic a natural hormone your body already produces. The active ingredient in Ozempic is semaglutide, a lab-made version of the GLP-1 hormone that’s been modified to last much longer in your body than the natural version does.
Understanding what “GLP-1” actually means helps clarify why Ozempic works the way it does, what it’s approved for, and how it compares to other drugs in the same family.
What GLP-1 Is and What It Does
GLP-1 stands for glucagon-like peptide-1, a hormone made in your small intestine. Your body releases it after you eat, and it does several things at once: it signals your pancreas to release insulin, it blocks another hormone (glucagon) that raises blood sugar, it slows down how fast your stomach empties food, and it acts on areas of your brain that control hunger and fullness. In short, GLP-1 helps your body process meals efficiently and tells your brain when you’ve had enough.
The problem is that natural GLP-1 breaks down in your body within minutes. That’s where GLP-1 receptor agonist drugs come in. They’re engineered to bind to the same receptors as the natural hormone but resist being broken down quickly, so the effects last far longer.
How Ozempic Mimics the Hormone
Semaglutide, the active ingredient in Ozempic, is structurally similar to human GLP-1 but includes chemical modifications that extend its life in the bloodstream. One key change helps it attach to a protein in your blood called albumin, which acts as a carrier and keeps the drug circulating for days instead of minutes. Another modification protects it from being chopped apart by an enzyme that normally destroys GLP-1 almost immediately. These changes are why Ozempic only needs to be injected once per week.
Once in your system, semaglutide activates the same pathways the natural hormone would. It boosts insulin release when blood sugar is elevated, suppresses glucagon, delays gastric emptying so you absorb sugar more gradually, and acts on the central nervous system to reduce appetite. It also influences fat metabolism, prompting your body to break down stored fat in white adipose tissue and improve energy expenditure.
What Ozempic Is Approved For
The FDA has approved Ozempic for two specific uses in adults with type 2 diabetes: improving blood sugar control (alongside diet and exercise) and reducing the risk of major cardiovascular events like heart attack, stroke, and cardiovascular death in people who also have established heart disease. It is not approved for type 1 diabetes.
This is an important distinction because the same active ingredient, semaglutide, is sold under a different brand name, Wegovy, for chronic weight management. The doses differ, and the approvals are separate. People sometimes assume Ozempic is “the weight loss drug,” but its labeled purpose is diabetes and cardiovascular risk reduction.
How Ozempic Is Dosed
Ozempic is a once-weekly injection given under the skin, on the same day each week, with or without food. The starting dose of 0.25 mg is intentionally below the therapeutic level. Its purpose is to let your body adjust and minimize side effects like nausea. After four weeks at this introductory dose, you move up to 0.5 mg. From there, your prescriber may increase the dose further based on your blood sugar response, up to a maximum of 2 mg per week.
This gradual ramp-up matters. GLP-1 drugs slow digestion significantly, and jumping to a full dose right away tends to cause more gastrointestinal discomfort. The titration schedule gives your gut time to adapt.
Cardiovascular Benefits Beyond Blood Sugar
One of the more significant findings around semaglutide is its effect on heart health. In the SELECT trial, which studied patients with obesity and established cardiovascular disease (but not diabetes), semaglutide reduced major adverse cardiovascular events by 20%. This included heart attacks, strokes, and death from cardiovascular causes. That result is part of why Ozempic carries an FDA-approved cardiovascular indication for people with type 2 diabetes and existing heart disease.
The cardiovascular benefits appear to go beyond what you’d expect from blood sugar improvements alone. GLP-1 receptor activation has been linked to reduced inflammation and changes in how the body handles lipids, though the full picture of why these drugs protect the heart is still being studied.
Other GLP-1 Drugs and How They Compare
Ozempic isn’t the only GLP-1 receptor agonist on the market. Liraglutide (sold as Victoza for diabetes and Saxenda for weight loss) was an earlier entry in the class and requires daily rather than weekly injections. Dulaglutide (Trulicity) is another weekly option used for type 2 diabetes.
A newer category pushes the concept further. Tirzepatide, sold as Mounjaro for diabetes and Zepbound for weight loss, is a dual agonist. It activates both the GLP-1 receptor and a second receptor called GIP (glucose-dependent insulinotropic polypeptide). Because it works through two hormonal pathways instead of one, tirzepatide may produce greater weight loss than semaglutide in some patients. Ozempic, by contrast, is a pure GLP-1 agonist, targeting only the one receptor.
There are also compounded versions of semaglutide circulating, sometimes sold using salt forms like semaglutide sodium or semaglutide acetate. The FDA has flagged these as different active ingredients from what’s in approved drugs, and they haven’t been evaluated for safety or effectiveness through the standard approval process.
Why GLP-1 Drugs Reduce Appetite
The weight loss associated with GLP-1 drugs like Ozempic comes from a combination of effects. Slowed stomach emptying means food sits in your digestive tract longer, which physically extends the feeling of fullness after a meal. But the bigger driver is what happens in the brain. Semaglutide crosses into the central nervous system and acts on appetite-regulating centers, reducing hunger signals and increasing feelings of satiety. People on these medications consistently report that they simply think about food less and feel satisfied with smaller portions.
At the tissue level, GLP-1 receptor activation also shifts how your body handles fat. It stimulates pathways that break down stored fat (triglycerides) in white adipose tissue and promotes fat oxidation, essentially encouraging your body to use stored energy rather than keep accumulating it. This metabolic effect works alongside the appetite reduction to produce meaningful weight changes over time.